Generate Biomedicines

About

Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.

Somerville,Massachusetts,United States
251 - 500
https://generatebiomedicines.com

Highlights

Details

Last Funding Type: Series B
Last Funding Money Raised: $370M
Industries: Biotechnology,Health Care,Medical,Product Research
Founded date: Jan 1, 2018
Number Of Employee: 251 - 500
Operating Status: Active
Legal Name: Generate Biomedicines, Inc.
Also Known As: Generate:Biomedicines

Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines. It pioneers in the field of Generative Biology, a revolutionary approach to drug development that allows them to program protein-based modalities for the first time.

The company was founded in 2018 and is headquartered in Somerville, Massachusetts.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

2

$420M

Generate Biomedicines has raised a total of $420M in funding over 2 rounds. Their latest funding was raised on Nov 18, 2021 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 18, 2021	Series B	$370M	8	—	—	Detail
Sep 10, 2020	Series Unknown	$50M	1	Flagship Pioneering	—	Detail

Investments

Number of Investments

Number of Lead Investments

11

0

Generate Biomedicines has made 11 investments. Their most recent investment was on Aug 31, 2021, when Syndicate raised $20M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Aug 31, 2021 Syndicate	Series A	$20M	Cryptocurrency	—
Feb 5, 2020 Transparent Financial Systems	Series A	$14M	Banking	—
Oct 5, 2019 Haystack	Pre-seed	$2M	Human Resources	—
Jan 24, 2019 Liquid Death	Seed	$1.60M	Food and Beverage	—
Oct 23, 2018 Envoy	Series B	$43M	Facility Management	—

Investors

Number of Lead Investors

Number of Investors

1

8

Generate Biomedicines is funded by 8 investors. Abu Dhabi Investment Authority and Alaska Permanent Fund are the most recent investors.

Investor Name	Lead Investor	Funding Round
Abu Dhabi Investment Authority	—	Series B
Alaska Permanent Fund	—	Series B
Altitude Life Science Ventures	—	Series B
ARCH Venture Partners	—	Series B
Fidelity Management and Research Company	—	Series B
Flagship Pioneering	—	Series B
Morningside Venture Investments	—	Series B
T. Rowe Price	—	Series B